ADD CONDITION
Numbify Sanitize
Last content change checked dailysee data sync status
This product has been discontinued
- Active ingredients
- Lidocaine Hydrochloride 400 mg/10000 mg
- Benzalkonium Chloride 13 mg/10000 mg
- Other brand names
- 2677 First Aid Burn Cream (by Prostat First Aid Llc)
- Afassco First Aid Burn Cream (by Afassco Inc.)
- Alocane Max (by Quest Products Llc)
- Alocane Max (by Quest Products Llc)
- Alocane Max (by Quest Products Llc)
- Alocane Plus (by Quest Products Llc)
- Alocane Plus (by Quest Products, Inc.)
- Alocane Plus (by Quest Products, Inc.)
- Antibacterial Lidocaine Wound Gel (by Aso Llc)
- Antibacterial Lidocaine Wound Gel (by Cvs Pharmacy)
- Antibacterial Lidocaine Wound Gel (by Walgreens)
- Antibacterial Lidocaine Wound Gel (by Water-Jel Technologies, Llc)
- Aosi Healthcare Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Aramark Burn Cream (by Western First Aid Safety Dba Aramark)
- Astonea Burn Cream (by Astonea Labs Private Limited)
- Burn (by Ningbo Tianbo First Aid Product Co. , Ltd.)
- Burn Cream (by Trifecta Pharmaceuticals Usa Llc)
- Burn First Aid (by Dynarex Corporation)
- Crane Safety Burn (by Crane Safety Llc)
- Cvs Health Antiseptic Wound Wash (by Cvs Pharmacy)
- Cvs Pain Relieving First Aid Antiseptic (by Cvs Pharmacy)
- Dg Health (by Dollar General Corporation)
- Dynarex Burn Cream (by Dynarex Corporation)
- First Aid Antiseptic (by Dollar General)
- First Aid Antiseptic (by Meijer)
- First Aid Antiseptic (by Premier Value)
- First Aid Antiseptic (by Rite Aid)
- First Aid Antiseptic (by Walgreens)
- First Aid Burn (by Epic Medical Supply Corp)
- First Aid Burn (by Water-Jel Technologies)
- First Aid Burn Cream (by Davemed Healthcare Co. , Ltd)
- First Aid Burn Cream (by Front Line Safety)
- First Aid Burn Cream (by Prostat First Aid Llc)
- First Aid Burn Cream (by Prostat First Aid Llc)
- First Shield (by Unishield)
- Firstar Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Health and Beyond Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Hurricaine One (by Beutlich Pharmaceuticals Llc)
- Levigosp (by Topicare Management, Llc)
- Levigosp (by Topicare Management, Llc)
- Medi-First (by Orazen Inc)
- Medi-First (by Orazen Inc)
- Meijer Maximum Strength (by Meijer Distribution, Inc.)
- Mueller First Aid Antiseptic (by Mueller Sports Medicine, Inc.)
- Numbify Sanitize (by Ridge Properties)
- Numbify Sanitize (by Ridge Properties)
- Numbify Sanitize (by Ridge Properties)
- Pain Relieving Cleansing (by Target)
- Pain Relieving Cleansing Spary (by Trifecta Pharmaceuticals Usa, Llc.)
- Proheal Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Roosin Burn (by Roosin Medical Co. , Ltd)
- Safly Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Top Safety First Aid Burn Cream (by Top Safety Products Company Inc)
- View full label-group details →
- Dosage form
- Gel
- Route
- Topical
- Prescription status
- OTC (over the counter)
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2020
- Label revision date
- April 29, 2020
- Drug Information (PDF)
- Prescribing information, PDF file
- Active ingredients
- Lidocaine Hydrochloride 400 mg/10000 mg
- Benzalkonium Chloride 13 mg/10000 mg
- Other brand names
- 2677 First Aid Burn Cream (by Prostat First Aid Llc)
- Afassco First Aid Burn Cream (by Afassco Inc.)
- Alocane Max (by Quest Products Llc)
- Alocane Max (by Quest Products Llc)
- Alocane Max (by Quest Products Llc)
- Alocane Plus (by Quest Products Llc)
- Alocane Plus (by Quest Products, Inc.)
- Alocane Plus (by Quest Products, Inc.)
- Antibacterial Lidocaine Wound Gel (by Aso Llc)
- Antibacterial Lidocaine Wound Gel (by Cvs Pharmacy)
- Antibacterial Lidocaine Wound Gel (by Walgreens)
- Antibacterial Lidocaine Wound Gel (by Water-Jel Technologies, Llc)
- Aosi Healthcare Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Aramark Burn Cream (by Western First Aid Safety Dba Aramark)
- Astonea Burn Cream (by Astonea Labs Private Limited)
- Burn (by Ningbo Tianbo First Aid Product Co. , Ltd.)
- Burn Cream (by Trifecta Pharmaceuticals Usa Llc)
- Burn First Aid (by Dynarex Corporation)
- Crane Safety Burn (by Crane Safety Llc)
- Cvs Health Antiseptic Wound Wash (by Cvs Pharmacy)
- Cvs Pain Relieving First Aid Antiseptic (by Cvs Pharmacy)
- Dg Health (by Dollar General Corporation)
- Dynarex Burn Cream (by Dynarex Corporation)
- First Aid Antiseptic (by Dollar General)
- First Aid Antiseptic (by Meijer)
- First Aid Antiseptic (by Premier Value)
- First Aid Antiseptic (by Rite Aid)
- First Aid Antiseptic (by Walgreens)
- First Aid Burn (by Epic Medical Supply Corp)
- First Aid Burn (by Water-Jel Technologies)
- First Aid Burn Cream (by Davemed Healthcare Co. , Ltd)
- First Aid Burn Cream (by Front Line Safety)
- First Aid Burn Cream (by Prostat First Aid Llc)
- First Aid Burn Cream (by Prostat First Aid Llc)
- First Shield (by Unishield)
- Firstar Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Health and Beyond Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Hurricaine One (by Beutlich Pharmaceuticals Llc)
- Levigosp (by Topicare Management, Llc)
- Levigosp (by Topicare Management, Llc)
- Medi-First (by Orazen Inc)
- Medi-First (by Orazen Inc)
- Meijer Maximum Strength (by Meijer Distribution, Inc.)
- Mueller First Aid Antiseptic (by Mueller Sports Medicine, Inc.)
- Numbify Sanitize (by Ridge Properties)
- Numbify Sanitize (by Ridge Properties)
- Numbify Sanitize (by Ridge Properties)
- Pain Relieving Cleansing (by Target)
- Pain Relieving Cleansing Spary (by Trifecta Pharmaceuticals Usa, Llc.)
- Proheal Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Roosin Burn (by Roosin Medical Co. , Ltd)
- Safly Burn (by Nantong Health & Beyond Hygienic Products Inc.)
- Top Safety First Aid Burn Cream (by Top Safety Products Company Inc)
- View full label-group details →
- Dosage form
- Gel
- Route
- Topical
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2020
- Label revision date
- April 29, 2020
- Manufacturer
- Ridge Properties
- Registration number
- part348
- NDC root
- 69804-089
- Drug Information (PDF)
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
It seems that the information provided does not include any specific details about a drug, such as its name, uses, or mechanism of action. Without these critical facts, I am unable to create a summary that describes what the drug is or what it is used for. If you have more specific information or a different set of details about a particular drug, please share that, and I would be happy to help!
Uses
It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.
Additionally, there are no details regarding any potential teratogenic effects (which are harmful effects on a developing fetus) or nonteratogenic effects (which do not affect fetal development). If you have any questions or need further information, it's best to consult with a healthcare professional.
Dosage and Administration
It seems that there are no specific dosage and administration instructions available for the medication you are inquiring about. This means that you won't find detailed guidelines on how much to take or how often to use it in the provided information.
For accurate dosage and administration, it's essential to refer to the accompanying image or consult your healthcare provider. They can give you the necessary instructions tailored to your individual needs. Always follow their guidance to ensure safe and effective use of the medication.
What to Avoid
There are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where the body becomes reliant on a substance).
Since there are no explicit "do not take" or "do not use" instructions, it's important to consult with your healthcare provider for personalized advice and to ensure this medication is appropriate for you. Always prioritize open communication with your doctor about any concerns or questions you may have regarding your treatment.
Side Effects
You may not experience any specific side effects from this medication, as there are no reported adverse reactions listed. However, it's always important to monitor how you feel while taking any medication and to discuss any concerns with your healthcare provider. If you notice anything unusual, be sure to reach out for guidance.
Warnings and Precautions
It's important to be aware of certain precautions when using this medication. While specific warnings and general precautions are not detailed, you should always consult your healthcare provider about any concerns or questions you may have regarding your health and the use of this medication.
If you experience any unusual symptoms or side effects, stop taking the medication immediately and contact your doctor for guidance. Additionally, if you find yourself in a medical emergency, seek emergency help right away. Regular check-ups and lab tests may be necessary to monitor your health while on this medication, so be sure to follow your doctor's recommendations.
Overdose
If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include extreme drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.
In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.
Pregnancy Use
It is important to know that the safety of this medication during pregnancy has not been established. Because of potential risks to the developing fetus, it is advised that you do not use this medication if you are pregnant. Always consult with your healthcare provider for guidance and to discuss any concerns regarding medication use during pregnancy. Your health and the health of your baby are the top priority.
Lactation Use
If you are breastfeeding, it's important to be aware that some substances can be passed into your breast milk. The effects of this particular product on nursing infants have not been thoroughly studied, so it's best to exercise caution when using it while breastfeeding. Always consult with your healthcare provider to discuss any concerns and ensure the safety of both you and your baby.
Pediatric Use
Currently, there is no specific information available regarding the use of this medication in children. This means that there are no recommended ages, dosage differences, or safety concerns outlined for pediatric patients (children). If you are considering this medication for a child, it is important to consult with a healthcare professional to ensure it is appropriate and safe for their specific needs. Always prioritize your child's health and well-being by seeking expert advice.
Geriatric Use
When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.
Renal Impairment
If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.
Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.
Hepatic Impairment
If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.
Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, and your healthcare team is there to support you.
Drug Interactions
It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.
Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.
Storage and Handling
To ensure the best quality and safety of your product, store it at room temperature and keep it away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.
Additional Information
The medication is administered topically, meaning it is applied directly to the skin. There are no additional details available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences. If you have any specific questions or concerns about using this medication, it's best to consult with your healthcare provider.
FAQ
What are the indications and usage for this drug?
No specific indications and usage details are provided in the text.
Are there any teratogenic effects associated with this drug?
No teratogenic effects are mentioned in the text.
What are the nonteratogenic effects of this drug?
No nonteratogenic effects are mentioned in the text.
What are the dosage and administration instructions?
No specific dosage and administration information is provided in the text.
Are there any contraindications for this drug?
No contraindications are listed.
Is this drug classified as a controlled substance?
No controlled substance classification or details are provided.
What should I know about using this drug during pregnancy?
Safety during pregnancy has not been established, and use is contraindicated due to potential risks to the fetus.
Can nursing mothers use this drug?
Nursing mothers should be cautious as the effects on a nursing infant are not well studied.
How should I store this drug?
Store at room temperature, protect from light, keep the container tightly closed, and discard after opening.
What is the route of administration for this drug?
The route of administration is topical.
Packaging Info
Below are the non-prescription pack sizes of Numbify Sanitize (benzalkonium chloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Gel |
| ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Gel |
| ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Gel |
| ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Drug Information (PDF)
This file contains official product information for Numbify Sanitize, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.
Description
The product is identified by the SPL code 34089-3. No specific description details are provided in the text.
Uses and Indications
This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.
There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider this information when evaluating treatment options for their patients.
Dosage and Administration
No specific dosage and administration information is available in the provided text. Healthcare professionals are advised to refer to the accompanying image for detailed instructions regarding dosage and administration. It is essential to follow the guidelines presented in the image to ensure proper use of the medication.
Contraindications
There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.
Warnings and Precautions
Healthcare professionals should be aware of the critical importance of monitoring patients for potential adverse effects and ensuring safe use of the medication.
In the event of any severe or unexpected reactions, it is imperative to seek emergency medical assistance immediately. Healthcare providers should instruct patients to discontinue use of the medication and contact their physician if they experience any concerning symptoms or side effects.
Regular laboratory tests may be necessary to monitor the patient's response to treatment and to identify any potential complications early. It is essential to establish a routine for these tests to ensure patient safety and effective management of their condition.
Healthcare professionals are encouraged to remain vigilant and proactive in assessing the risks associated with the medication, ensuring that all precautions are taken to safeguard patient health.
Side Effects
There are no specific adverse reactions or side effects listed in the provided data. As such, no detailed information regarding serious or common adverse reactions, clinical trial insights, or postmarketing experiences can be presented. It is important for healthcare professionals to monitor patients for any unexpected reactions and to report any adverse events as they arise.
Drug Interactions
No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.
Packaging & NDC
Below are the non-prescription pack sizes of Numbify Sanitize (benzalkonium chloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Gel |
| ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Gel |
| ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Gel |
| ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Pediatric Use
There is no specific pediatric use information, recommended ages, dosing differences, safety concerns, or special precautions for children provided in the prescribing information. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pediatric patients, as the safety and efficacy in this population have not been established.
Geriatric Use
Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.
Pregnancy
Safety during pregnancy has not been established for this medication. Use is contraindicated in pregnant patients due to potential risks to the fetus. Healthcare professionals should carefully consider the benefits and risks when prescribing this medication to women of childbearing potential.
Lactation
Nursing mothers should be aware of the potential for excretion of this product in breast milk. The effects of this product on a nursing infant are not well studied; therefore, caution is advised when using this product while breastfeeding.
Renal Impairment
Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function. Regular monitoring of renal function is advisable to ensure safe and effective use of the medication in this population.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.
Overdosage
In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.
It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.
In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.
Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. It is crucial for healthcare professionals to consult relevant clinical guidelines and toxicology resources to determine the most appropriate management strategies.
In summary, while no specific overdosage information is provided, vigilance and prompt intervention are paramount in managing potential overdose situations.
Nonclinical Toxicology
No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.
Postmarketing Experience
No postmarketing experience details are available in the insert text.
Patient Counseling
Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.
Storage and Handling
The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature to maintain its efficacy.
To ensure optimal preservation, the product must be protected from light exposure. Additionally, it is crucial to keep the container tightly closed when not in use to prevent contamination and degradation. Once opened, the product should be discarded after use to ensure safety and effectiveness.
Additional Clinical Information
The route of administration for the product is topical. No additional information is available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.
Drug Information (PDF)
This file contains official product information for Numbify Sanitize, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.